The CEO of Catalyst Pharmaceuticals expressed optimism about...
The CEO of Catalyst Pharmaceuticals expressed optimism about the appointment of Michael W. Kalb as new CFO and the promotions, which are expected to drive transformative contributions to the company's short and long-term growth.
Press Release: Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment